Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

EU Database Depends On Nomenclature Tips From Manufacturers – J&J Rep

This article was originally published in The Gray Sheet

Executive Summary

European manufacturers should work with national standards bodies and trade groups to ensure that the Global Medical Device Nomenclature is timely, accurate and comprehensive, according to Johnson & Johnson European Compliance Director Rob Lally

You may also be interested in...



International News In Brief

EUDAMED: Competent authorities will be able to access adverse event reports throughout Europe by year-end in the first phase of the European Database on Medical Devices. Notified bodies and other parties, however, likely will not have access until 2004, according to the European Commission (1"The Gray Sheet" Feb. 10, 2003, p. 26)...

International News In Brief

EUDAMED: Competent authorities will be able to access adverse event reports throughout Europe by year-end in the first phase of the European Database on Medical Devices. Notified bodies and other parties, however, likely will not have access until 2004, according to the European Commission (1"The Gray Sheet" Feb. 10, 2003, p. 26)...

GMDN Classification System Could Help Revamp EUDAMED Database

The recently finalized version of the Global Medical Device Nomenclature (GMDN) system could give a new lease on life to the nascent European Database for Medical Devices (EUDAMED), which has been struggling to gain acceptance among EU member countries.

Latest Headlines
See All
UsernamePublicRestriction

Register

MT017864

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel